American College of Clinical Pharmacy
      Search      Cart
         

Research and Scholarship Core Faculty

Jimmi Hatton Kolpek , Pharm.D., FCCP, FCCM, FNAP (Director)

Jimmi  Hatton Kolpek , Pharm.D., FCCP, FCCM, FNAP

Jimmi Hatton Kolpek is a tenured professor practicing and conducting research on the care of patients with neurologic injury. After serving as a department chair (2007–2011), her clinical practice transitioned from neurologic intensive care to rehabilitation and ambulatory care of patients with spinal cord and brain injury. Through collaborative partnerships with colleagues from the Kentucky Appalachian Rural Rehabilitation Network (https://karrn.org/) and the Cardinal Hill Rehabilitation Hospital (www.cardinalhillhealthsouth.com/), she has targeted the challenges of polypharmacy after neurologic injury. Hatton Kolpek continues pharmacokinetic and pharmacodynamic research projects with colleagues from neurosurgery and the Spinal Cord and Brain Injury Research Center (www.mc.uky.edu/scobirc/). Hatton Kolpek’s research has been funded by the NIH, private foundations, industry, and the university.

She is a vice chair of the University of Kentucky IRB. She serves on the editorial board of Neurocritical Care and is a member of the Neurocritical Care Society Research Committee. She also provides instruction to professional students, residents, and graduate students in the colleges of pharmacy and medicine in evidence-based medicine, advanced pharmacy practice, traumatic brain injury, and clinical research ethics.

In 2015, Hatton Kolpek became the director of the ACCP Academy Research and Scholarship Certificate Program and participates as a mentor in the ACCP MeRIT program. In 2017, Hatton Kolpek was recognized as a distinguished scholar and fellow in the National Academies of Practice.

William L. Baker Jr., Pharm.D., FCCP, FACC, FAHA

William L. Baker Jr., Pharm.D., FCCP, FACC, FAHA

William L. Baker, Pharm.D., FCCP, FACC, FAHA is Associate Professor at the University of Connecticut, School of Pharmacy.

Dr. Baker received his Bachelor of Science and Doctor of Pharmacy degrees from the University of Connecticut, School of Pharmacy in 2000 and 2002, respectively. After working as a clinical pharmacist for a few years at Bayhealth Medical Center in Milford Delaware, he completed a 2-year cardiovascular pharmacology & outcomes fellowship at Hartford Hospital in 2008 under the direction of Drs. Michael White and Craig Coleman.

Dr. Baker’s practice/research interests include comparative effectiveness for medical decision making, efficacy and effectiveness of cardiovascular drugs, systematic review and meta-analysis and evidence-based medicine. He has received grant funding from various federal, pharmaceutical, and foundation sources. To date, he has published over 120 manuscripts in peer-reviewed journals and won numerous awards including the 2012 ACCP New Investigator Award.

Gary L. Cochran, Pharm.D., S.M.

Gary L. Cochran, Pharm.D., S.M.

Gary L. Cochran is an associate professor at the University of Nebraska Medical Center (UNMC). He received a B.S. degree in business administration from the University of Nebraska in 1991, a Pharm.D. degree from UNMC in 1997, and an M.S. degree in epidemiology from the Harvard School of Public Health in 2004. He completed a pharmacy practice residency and a pharmacoeconomics and outcomes research fellowship at UNMC in 1998 and 2000, respectively.

Cochran’s research objective is to improve the safety and quality of rural health care through advancing and disseminating knowledge that will affect both clinical care and health policy. His current research evaluates the effectiveness of medication use systems and health information technologies to improve health care safety and quality.

Jacqueline McLaughlin, Ph.D., M.S.

Jacqueline McLaughlin, Ph.D., M.S.

Jacqueline McLaughlin received her B.S. degree in biological engineering from North Carolina State University, her M.S. degree in biomedical engineering from the University of Memphis, and her Ph.D. degree in educational research and policy analysis from North Carolina State University. She spent 1 year as a postdoctoral fellow with the Office of Strategic Planning and Assessment (OSPA) at the UNC Eshelman School of Pharmacy and currently serves the school as an assistant professor of educational innovation and research and as the director of OSPA.

McLaughlin is involved in educational research that examines relationships between student characteristics, engagement, and performance during a curriculum. Her research experience and interests extend across the context of admissions, classroom engagement, experiential learning, and extracurricular activities.

Mary T. Roth McClurg, Pharm.D., MHS, FCCP

Mary T. Roth McClurg, Pharm.D., MHS, FCCP

Mary Roth McClurg, PharmD, MHS, is Professor and Executive Vice Dean-Chief Academic Officer at the UNC Eshelman School of Pharmacy. She also serves as Associate Director for Academic Innovation with the Eshelman Institute for Innovation.

Roth McClurg practiced as a clinical pharmacist in inpatient medicine within the VA Health System (1995-1998) and then transitioned to clinical practice in primary care and geriatrics, providing direct patient care as part of a collaborative team (1998-2006). Roth McClurg has focused her research efforts on advancing the role of the clinical pharmacist in primary care, with the goal of optimizing medication use and improving care in patients with multiple chronic diseases. She is currently serving as co-principal investigator on a $2.4 million grant from ACCP to enhance primary care medical practice through comprehensive medication management.

In addition to her research, Roth McClurg has played an integral leadership role in the design, implementation, and evaluation of UNC’s transformative new Pharm.D. curriculum to better position students to meet the health care needs of society. The school’s new Pharm.D. program was implemented in the fall of 2015.

Roth McClurg was involved in co-leading the School’s development of the 2012–2017 Strategic Plan as well as the School’s recent 2018-2020 Strategic Plan 2.0. She served as director of the Office of Strategic Planning and Assessment at the UNC Eshelman School of Pharmacy from 2009–2013.

Roth McClurg completed her Pharm.D. and residency training at the St. Louis College of Pharmacy and received her Masters of Health Sciences in Clinical Research from Duke University School of Medicine. She is a fellow of the American College of Clinical Pharmacy.

Daniela Moga, M.D., Ph.D.

Daniela Moga, M.D., Ph.D.

Dr. Moga is an Assistant Professor in the Department of Pharmacy Practice and Science and an affiliated faculty member in the Institute for Pharmaceutical Outcomes & Policy (IPOP) and Sanders-Brown Center on Aging. She also holds a joint appointment as Assistant Professor in the Department of Epidemiology in the College of Public Health. Dr. Moga received her M.D. and residency training in Epidemiology and Public Health from the University of Medicine and Pharmacy in Cluj-Napoca, Romania, and her Ph.D. in Epidemiology from the University of Iowa. Her research interests include pharmacoepidemiology and health outcomes research. Currently, her focus is on evaluating medication use and effects, including quality of life among the elderly with multiple comorbid conditions, cognitive impairment and/or in long-term care. She is also involved in conducting randomized clinical trials to test the impact of medication therapy management interventions in patients with different levels of cognitive impairment.

Margie E. Snyder, Pharm.D., MPH

Margie E. Snyder, Pharm.D., MPH

Dr. Snyder is an associate professor of pharmacy practice at Purdue University College of Pharmacy. She received her Doctor of Pharmacy and Master of Public Health degrees from the University of Pittsburgh. She also completed a PGY1 pharmacy practice residency with an emphasis in community care at the University of Pittsburgh in partnership with Rite Aid Corporation, followed by a two-year community practice research fellowship at the University of Pittsburgh. Her work is focused on the study of pharmacist-provided medication therapy management services. Dr. Snyder is Co-Director of Community Pharmacy Programs. In this role, she has worked to establish the Medication Safety Research Network of Indiana (Rx-SafeNet), a state-wide practice-based research network of community pharmacies. She directs the College’s Community Practice Research Fellowship Program and also serves as a preceptor for the PGY1 community pharmacy residencies affiliated with the College.